⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRVI News
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Oligonucleotide CDMO Market worth $11.14 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
AGNC
TMO
MRVI
Form 8-K
sec.gov
MRVI
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
businesswire.com
MRVI
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
businesswire.com
MRVI
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
businesswire.com
MRVI
Form 8-K
sec.gov
MRVI
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
businesswire.com
MRVI
Form 8-K
sec.gov
MRVI
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
businesswire.com
MRVI
Form 8-K
sec.gov
MRVI